首页> 外国专利> MEDICAMENTAL TREATMENT OF FEMALE AND MALE FEMALE DYSFUNCTIONS WITH THE VARIOUS ANTIDEPRESSIVE GROUPS; ASSOCIATED TO ANDROGEN DRUGS (TESTOSTERONE), ESTROGENICS (ESTRADIOL), INBITORIAL NEUROTRANSMISSOR (GABA) AND SOME VASODILATORS, WHICH HAVE PENIAN EFFECTIVE ACTION (VARDENAFIL, SILDENAFIL AND TADALAFIL). MAY BE IN ASSOCIATION OR ISOLATED AND BE INDUSTRIALIZED AND MARKETED, IN VARIOUS FORMS OF PRESENTATION AND POSOLOGY. THERAPEUTIC INDICATION FOR PATIENTS WITH DEPRESSION FRAMEWORK AND / OR BIPOLAR DISORDER, WHO NEED TO USE ANTIDEPRESSIVE DRUGS, OBJECTING THE REDUCTION OR ABOLITION OF THE SEXUAL EFFECTS OF ANTIDEPRESSIONS, IMPROVING SEX PERFORMANCE, IN BOTH SEX.

MEDICAMENTAL TREATMENT OF FEMALE AND MALE FEMALE DYSFUNCTIONS WITH THE VARIOUS ANTIDEPRESSIVE GROUPS; ASSOCIATED TO ANDROGEN DRUGS (TESTOSTERONE), ESTROGENICS (ESTRADIOL), INBITORIAL NEUROTRANSMISSOR (GABA) AND SOME VASODILATORS, WHICH HAVE PENIAN EFFECTIVE ACTION (VARDENAFIL, SILDENAFIL AND TADALAFIL). MAY BE IN ASSOCIATION OR ISOLATED AND BE INDUSTRIALIZED AND MARKETED, IN VARIOUS FORMS OF PRESENTATION AND POSOLOGY. THERAPEUTIC INDICATION FOR PATIENTS WITH DEPRESSION FRAMEWORK AND / OR BIPOLAR DISORDER, WHO NEED TO USE ANTIDEPRESSIVE DRUGS, OBJECTING THE REDUCTION OR ABOLITION OF THE SEXUAL EFFECTS OF ANTIDEPRESSIONS, IMPROVING SEX PERFORMANCE, IN BOTH SEX.

机译:具有各种抗抑郁药基团的女性和男性功能失调的药物治疗;与雄激素药物(睾丸激素),雌激素药(雌激素),生物神经递质(GABA)和一些使用过便尿的麻醉剂有关,它们具有P烯的有效作用(瓦地那非,西地那非和他达拉非)。可能以各种形式和形式在协会中被隔离或被工业化和推广。患有抑郁症框架和/或双歧疾病的患者的治疗适应症,需要使用抗抑郁药,目的是减少或消除抗抑郁药的性作用,从而改善性行为。

摘要

This patent refers to the chemical -pharmaceutical sector. This patent is characterised by associating various groups of antidepressant drugs with various other groups of substances, whether associated or isolated, such as: groups of androgens (testosterone),Neurotransmitter inhibitory -gaba, estrogen (estradiol),Some vasodilators with penile erective action, such as vardenafil, sildenafil and tadalafil, totalling in their associations 205 new pharmacological products, for treatments of the different female and male sexual dysfunctions, which affect the following stages: stage of the Sejo, stimulation phase, orgasm phase, producing increased sexual function of patients who make use of antidepressant drugs, which, for the most part, produce reduced sexual performance,In both men and women. The benefit is to improve these difficulties in men with premature ejaculation who have to undergo treatments with antidepressant drugs, of all kinds, another group is the ones with erective difficulties, or who already have or are produced by the anti -depressant medicine Resentful. The vast majority of antidepressants, regardless of the group to which they belong, produce a reduction in sexual desire in both sexes, and this patent proposes some medications that can improve these dysfunctions, as well as, in women in weather,Many of them already possess or begin to produce sexual dysfunctions with the use of antidepressants. Can be industrialised and marketed in the most different forms and posologies.
机译:该专利涉及化学-制药领域。该专利的特点是将各种抗抑郁药与各种其他物质(无论是相关的还是分离的)相关联,例如:雄激素(睾丸激素),神经递质抑制药-gaba,雌激素(雌二醇),一些具有阴茎勃起作用的血管扩张药,如vardenafil,sildenafil和tadalafil,共计有205种新药理产品,用于治疗不同的男女性功能障碍,这些功能性障碍影响以下阶段:Sejo阶段,刺激阶段,性高潮阶段,产生性功能增强使用抗抑郁药的患者,在大多数情况下,这种抗抑郁药都会导致男性和女性的性能力下降。这样做的好处是可以改善必须接受各种抗抑郁药治疗的早泄男性的这些困难,另一类是勃起困难的男性,或者已经或已经由抗抑郁药Resentful生产。绝大多数抗抑郁药,无论属于哪个类别,都会导致两性的性欲降低,并且该专利提出了一些可以改善这些功能障碍的药物,以及在天气状况良好的女性中,许多药物已经使用抗抑郁药会导致或开始产生性功能障碍。可以以最不同的形式和形式进行工业化和销售。

著录项

  • 公开/公告号BR102017021360A2

    专利类型

  • 公开/公告日2019-04-24

    原文格式PDF

  • 申请/专利权人 EDSON CLARO DO NASCIMENTO;

    申请/专利号BR20171021360

  • 发明设计人 EDSON CLARO DO NASCIMENTO;

    申请日2017-10-05

  • 分类号A61K31/565;A61P15/10;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:39

相似文献

  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号